12.9% Above Target

MCRI's consensus price target is $110.5, -12.9% below the current price of $126.8. The 9 analysts tracking MCRI see downside risk at present valuations.

MCRI has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is mixed, with 6 Hold ratings making up the largest segment. The consensus 12-month price target of $110.5 implies -12.9% downside from current levels.

With a forward P/E of 19.1796x, MCRI trades at a relatively low valuation. The consensus target of $110.5 implies -12.9% move, suggesting the market may be pricing in risks.

The most bullish Wall Street analyst has a price target of $124 for MCRI, while the most conservative target is $97. The consensus of $110.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $201 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

MCRI is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 6 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month MCRI stock forecast based on 9 Wall Street analysts shows a consensus price target of $110.5, with estimates ranging from $97 (bear case) to $124 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $153, with bear/bull scenarios of $96/$201.

Our quantitative valuation model calculates MCRI's fair value at $153 (base case), with a bear case of $96 and bull case of $201. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 46/100.

MCRI trades at a forward P/E ratio of 19.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 23.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Analysts are cautious on MCRI, with 0 Sell ratings and a price target of $110.5 (-12.9% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

MCRI analyst price targets range from $97 to $124, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $110.5 consensus represents the middle ground. Our model's $96-$201 range provides an independent fundamental perspective.